PDGFRB and neoplasm: Catuogno et al. generated two different constructs to deliver the tumor suppressor anti-miR 222, one conjugated to the Axl aptamer (GL21.T), and another coupled to the antagonistic aptamer against the platelet-derived growth factor receptor β (PDGFRβ).